FDA didn't disclose safety panel's ties to Bayer, WSJ says

When an FDA advisory panel voted to support Bayer's birth control pills after new data emerged on their potential to cause blood clots, the agency didn't disclose that three of the committee members have served as consultants, speakers, or researchers for the German company, The Wall Street Journal reports. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.